Parkinson's disease and skin
- PMID: 33248395
- DOI: 10.1016/j.parkreldis.2020.11.017
Parkinson's disease and skin
Abstract
Parkinson's disease is associated with a variety of dermatologic disorders and the study of skin may provide insights into pathophysiological mechanisms underlying this common neurodegenerative disorder. Skin disorders in patients with Parkinson's disease can be divided into two major groups: 1) non-iatrogenic disorders, including melanoma, seborrheic dermatitis, sweating disorders, bullous pemphigoid, and rosacea, and 2) iatrogenic disorders related either to systemic side effects of antiparkinsonian medications or to the delivery system of antiparkinsonian therapy, including primarily carbidopa/levodopa, rotigotine and other dopamine agonists, amantadine, catechol-O-methyl transferase inhibitors, subcutaneous apomorphine, levodopa/carbidopa intestinal gel, and deep brain stimulation. Recent advances in our understanding of the role of α-synuclein in peripheral tissues, including the skin, and research based on induced pluripotent stem cells derived from skin fibroblasts have made skin an important target for the study of Parkinson's disease pathogenesis, drug discovery, novel stem cell therapies, and diagnostics.
Keywords: Apomorphine; Biopsy; Bullous pemphigoid; Deep brain stimulation; Diagnosis; Levodopa; Levodopa-carbidopa intestinal gel; Livedo reticularis; Melanoma; Nodules; Parkinson's disease; Rosacea; Seborrheic dermatitis; Skin; Sweating.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone.Parkinsonism Relat Disord. 2019 Jul;64:352-353. doi: 10.1016/j.parkreldis.2019.05.018. Epub 2019 May 11. Parkinsonism Relat Disord. 2019. PMID: 31101554 No abstract available.
-
Use of advanced therapies for Parkinson's disease in Norway.Tidsskr Nor Laegeforen. 2017 May 2;137(9):619-623. doi: 10.4045/tidsskr.16.0711. eCollection 2017 May. Tidsskr Nor Laegeforen. 2017. PMID: 28468476 English, Norwegian.
-
The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.Mov Disord Clin Pract. 2016 Sep 8;4(1):21-31. doi: 10.1002/mdc3.12425. eCollection 2017 Jan-Feb. Mov Disord Clin Pract. 2016. PMID: 30363435 Free PMC article. Review.
-
Apomorphine in the treatment of Parkinson's disease: a review.Arq Neuropsiquiatr. 2018 Dec;76(12):840-848. doi: 10.1590/0004-282X20180140. Arq Neuropsiquiatr. 2018. PMID: 30698208 Review.
-
[Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].Neuropsychopharmacol Hung. 2015 Dec;17(4):191-6. Neuropsychopharmacol Hung. 2015. PMID: 26727723 Review. Hungarian.
Cited by
-
How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?Sci Rep. 2024 Sep 17;14(1):21707. doi: 10.1038/s41598-024-71598-7. Sci Rep. 2024. PMID: 39289421 Free PMC article.
-
Phytocompounds and Nanoformulations for Anticancer Therapy: A Review.Molecules. 2024 Aug 9;29(16):3784. doi: 10.3390/molecules29163784. Molecules. 2024. PMID: 39202863 Free PMC article. Review.
-
Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology.Int J Mol Sci. 2024 Jun 28;25(13):7100. doi: 10.3390/ijms25137100. Int J Mol Sci. 2024. PMID: 39000207 Free PMC article. Review.
-
Causal association between atopic dermatitis and Parkinson's disease: A bidirectional Mendelian randomization study.Brain Behav. 2024 Mar;14(3):e3468. doi: 10.1002/brb3.3468. Brain Behav. 2024. PMID: 38468488 Free PMC article.
-
Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial.JMIR Dermatol. 2024 Mar 11;7:e49965. doi: 10.2196/49965. JMIR Dermatol. 2024. PMID: 38466972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical